I have sent the company numerous emails without any response so...

I have sent the company numerous emails without any response so far. Just curious if anyone else has had any luck in gaining a response?

Also they made it very clear that it would be difficult to negotiate any sort of deal with a Market Cap under 100m.
what is the catalyst that can rerate this to back over 100m?
Further data relating to HIV, Hep B, Hep C progress?

What is happening with the newly sort chinese consulting firm?

Will we need a phase 2a and possibly 2b trial to satisfy potential partners questions?

When are they expecting further analysis of bit225 009 data?

Im not going to lie, this has to be one of the most intriguing company's on the ASX but one that keeps alot of things very close to the chest. Maybe this is why it is so intriguing? Maybe it's not such a bad thing?

And I think Davisite raises a good question, What is the purpose of signing Locarnini to the BOD? An actual statement from the company, not just an obvious assumption that it relates to Hep B.

what and when will the next update be?

I have to say I am very excited for what's to come!

Cheers hope everyone is enjoying the long weekend!!